| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $6.8M | — | -13.1% |
| SG&A Expense | $3.8M | — | +30.0% |
| Operating Income | -$10.6M | — | +1.2% |
| Income Tax | $0 | — | — |
| Net Income | -$11.8M | — | -5.5% |
| EPS (Basic) | -$0.65 | — | +25.3% |
| EPS (Diluted) | -$0.65 | — | +25.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.9M | -19.5% | -18.5% |
| Current Assets | $16.2M | -16.1% | -22.6% |
| Total Assets | $22.7M | -12.3% | -19.4% |
| Current Liabilities | $7.2M | -10.9% | -36.7% |
| Long-term Debt | $9.5M | -5.3% | — |
| Total Liabilities | $24.1M | -0.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.6M | — | -15.1% |
| Financing Cash Flow | $8.0M | — | -22.3% |
| +25.4% |
| Stockholders' Equity | -$1.4M | -187.8% | -116.1% |